期刊文献+

阿利吉仑对大鼠肾纤维化TGF-β1/Smad信号通路的影响 被引量:5

Effects of Aliskiren on Rat Renal Interstitial Fibrosis TGF-β1 / Smad Signal Pathway
在线阅读 下载PDF
导出
摘要 目的探讨阿利吉仑对单侧输尿管梗阻大鼠肾间质纤维化的作用及机制。方法 24只雌性SD大鼠随机分为3组,Sham组、UUO组及aliskiren组,除Sham组外,UUO组及aliskiren组均行左侧输尿管结扎术。aliskiren组术前1 d开始灌胃给药,阿利吉伦50 mg/(kg·d),每日1次,连续2周。术后第14天处死大鼠,留取梗阻侧肾组织行HE染色和Masson染色,光镜下观察各组大鼠肾组织病理变化,免疫组化和Western印迹检测肾组织TGF-β1、Smad2和Smad7蛋白表达水平。结果阿利吉仑可明显减轻大鼠肾间质炎性细胞浸润、纤维组织增生及肾小管扩张和萎缩。免疫组化和Western印迹结果均显示:与Sham组相比,UUO组TGF-β1、Smad2表达明显上升,而Smad7表达明显下降(均P<0.05);与UUO组相比,aliskiren组TGF-β1、Smad2表达明显下降,Smad7表达明显上升(均P<0.05)。结论 TGF-β1/Smad信号通路与肾间质纤维化有关,阿利吉仑可抑制肾间质纤维化,其机制可能与下调TGF-β1、Smad2的表达和上调Smad7的表达有关。 Objective To investigate the mechanism of aliskiren on renal interstitial fibrosis in rats exerted unilateral ureteral obstruction. Methods 24 female Sprague-Dawley( SD) rats were randomly divided into 3 groups: Sham-operated group( Sham),UUO group( UUO) and aliskiren treated group( aliskiren). Except for Sham group,the UUO and aliskiren group underwent left ureteral ligation. Rats in aliskiren group were performed with intragastric administration of aliskiren( 50 mg / kg·d) at 1day before surgery,once per day and lasted for 2 weeks. All rats were sacrificed at 14 days after surgery. The pathological changes of the obstruction renal tissues were examined by HE and Masson staining. Immunohistochemistry and Western blot were applied to detect the protein expression of TGF-β1,Smad2 and Smad7. Results Aliskiren could significantly reduce inflammatory cell infiltration,fibroplasia,the expansion and atrophy of the tubular. Compared with Sham group,the protein expression of TGF-β1and Smad2 was increased significantly,but Smad7 was decreased significantly in UUO group( all P 〈0. 05). Compared with UUO group,the protein expression of TGF-β1 and Smad2 was decreased significantly,Smad7 was increased significantly in aliskiren group( all P 〈0. 05). Conclusion Aliskiren could relieve the renal interstitial fibrosis and fibrosis,and the mechanism of effects may be related to its down regulation TGF-β1,Smad2 and up regulation Smad7.
出处 《中南医学科学杂志》 CAS 2015年第1期26-30,38,共6页 Medical Science Journal of Central South China
基金 衡阳市科学技术局(2013KS34)
关键词 TGF-Β1 SMAD2 SMAD7 纤维化 阿利吉仑 梗阻性肾病 TGF-β1 Smad2 Smad7 Fibrosis Aliskiren Obstructive nephropathy
作者简介 通讯作者。E-mail:nhliangyu@163.com.
  • 相关文献

参考文献15

  • 1Tonelli M,Klarenbach SW,Lloyd AM,et al.Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes,especially with concomitant proteinuria[J].Kidney Int,2011,80(12):1306-1314.
  • 2Pan MM,Zhang MH,Ni HF,et al.Inhibition of TGF-β1/Smad signal pathway is involved in the effect of Cordyceps sinensis against renal fibrosis in 5/6 nephrectomy rats[J].Food Chem Toxicol,2013,58:487-494.
  • 3Fine LG,Orphanides C,Norman JT.Progressive renal disease:the chronic hypoxia hy Potheses[J].Kidney Int,1998,53(Suppl 65):S574-578.
  • 4Liu Y.Cellular and molecular mechanisms of renal fibrosis[J].Nat Rev Nephrol,2011,7(12):684-696.
  • 5Liu SF,Chang SY,Lee TC,et al.Dioscorea alata attenuates renal interstitial cellular fibrosis by regulating Smadand epithelial-mesenchymal transition signaling pathways[J].PLo S One,2012,7(11):e47482.
  • 6Lan HY.Diverse roles of TGF-β/Smads in renal fibrosis and inflammation[J].Int J Biol Sci,2011,7(7):1056-1067.
  • 7Kavsak P,Rasmussen RK,Causing CG,et al.Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degrada-tion[J].Mol Cell,2000,6:1365-1375.
  • 8Ebisawa T,Fukuchi M,Murakami G,et al.Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation[J].J Biol Chem,2001,276:12477-12480.
  • 9Chevalier RL,Forbes MS,Thornhill BA.Ureteral obstruction as a model of renal interstitial brosis and obstructive nephropathy[J].Kidney Int,2009,75(11):1145-1152.
  • 10Sica DA.Combination angiotensin converting enzyme inhibitor and angiotensin receptor blocker therapy:its role in clinical practice[J].J Clin Hypertens,2003,5(6):414-420.

二级参考文献21

  • 1杨勤,谢汝佳,韩冰,肖瑛,杨婷,方丽,龙义国,张国忠.转化生长因子胞内信号蛋白Smad2/3在糖尿病大鼠肾脏表达的动态观察及意义研究[J].中国病理生理杂志,2006,22(10):1879-1884. 被引量:21
  • 2Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis [ J ]. Am J Physiol Renal Physiol, 2002, 283 (5) : F861 - F875.
  • 3Liu FY, Li XZ, Peng YM, et al. Arkadia - Smad7 - mediated positive regulation of TGF - beta signaling in a rat model of tubulointerstitial fibrosis [ J ]. Am J Nephrol, 2007, 27(2) :176 - 183.
  • 4Kushibiki T, Nagata- Nakajima N, Sugai M, et al. Delivery of plasmid DNA expressing small interference RNA for TGF - beta type Ⅱ receptor by cationized gelatin to prevent interstitial renal fibrosis [ J]. J Control Release, 2005, 105(3) :318 -331.
  • 5Moon JA, Kim HT, Cho IS, et al. IN - 1130, a novel transforming growth factor - beta type I receptor kinase (ALKS) inhibitor, suppresses renal fibrosis in obstructive nephropathy [ J ]. Kidney Int, 2006, 70 (7) : 1234 - 1243.
  • 6Yokoi H, Mukoyama M, Sugawara A, Mori K, Nagae T, Makino H, Suganami T, Yahata K, Fujinaga Y, Tanaka I, Nakao K. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol. 2002; 282(5): F933-F942.
  • 7Chea SW, Lee KB. TGF-beta mediated epithelial mesenchymal transition in autosomal dominant polyeystic kidney disease. Yonsei Med J. 2009; 50(1): 105-111.
  • 8Brown KA, Ham AJ, Clark CN, Meller N, Law BK, Chytil A, Cheng N, Pietenpol JA, Moses HL. Identification of novel Smad2 and Smad3 associated proteins in response to TGF-betal. J Cell Biochem. 2008; 105(2) : 596 611.
  • 9Zuccato C, Bianchi N, Borgatti M, Lampronti I, Massei F, Favre C, Gambari R. Everolimus is a potent inducer of erythroid differentiation and gamma-globin gene expression in human erythroid cells. Acta Haematol. 2007; 117(3): 168-176.
  • 10Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006; 69(2): 213-217.

共引文献26

同被引文献66

  • 1赵雅妮,李惊子,王海燕.血管紧张素Ⅱ受体拮抗剂与血管紧张素转换酶抑制剂抗大鼠肾脏纤维化的作用及机制探讨[J].中华老年多器官疾病杂志,2002,1(1):36-40. 被引量:24
  • 2侯凡凡,谢迪.慢性肾脏病应用肾素-血管紧张素系统阻断剂的治疗目标[J].中华高血压杂志,2007,15(z1):32-34. 被引量:13
  • 3曹华,马红英,曹霞,黄新莉,张雪静,周晓红.外源性H_2S对肺纤维化大鼠肺组织转化生长因子-β1及结缔组织生长因子的干预作用[J].中国老年学杂志,2014,34(1):140-142. 被引量:8
  • 4Lee AS, Mira Avendano I, Ryu JH, et al. The burden of idiopathic pulmonary fibrosis: an unmet public health need[J]. Respir Med, 2014, 108(7):955-967.
  • 5Yang D, Yuan W, Lv C, et al. Dihydroartemisinin supresses inflammation and fibrosis in bleomycine -induced pulmonary fibrosis in rats[J]. Int J Clin Exp Pathol, 2015, 8(2): 1270-1281.
  • 6Song K, Li Q, Yin XY, et al. Hydrogen sulfide: a therapeutic candidate for Fibrotic disease? [J]. Oxid Med Cell Longev, 2015, 2015: 458720.
  • 7Fang L, Li H, Tang C, et al. Hydrogen sulfide attenuates the pathogenesis of pulmonary fibrosis induced by bleomycin in rats[J]. Can J Physiol Pharmacol, 2009, 87(7): 531-538.
  • 8Cao H, Zhou X, Zhang J, et al. Hydrogen sulfide protects against bleomyein-induced pulmonary fibrosis in rats by inhibiting NF-KB expression and regulating Thl/Th2 balance[J]. Toxieol Lett, 2014, 224(3): 387-394.
  • 9Szapiel SV, Elson NA, Fulmer JD, et al. Bleomycin-induce dinterstitial pulmonary disease in the nude, athymic mouse[J]. Am Rev Respir Dis, 1979, 120(4): 893-899.
  • 10Sheng J, Shim W, Wei H, et al. Hydrogen sulphide suppresses human atrial fibroblast proliferation and transformation to myofibroblasts[J]. J Cell Mol Med, 2013, 17(10): 1345-1354.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部